Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA.
Neurobiol Dis. 2012 Apr;46(1):93-100. doi: 10.1016/j.nbd.2011.12.049. Epub 2012 Jan 9.
There is increasing evidence that functional deficits in schizophrenia may be driven by a reduction in the signal-to-noise ratio (SNR) and consistent timing of neural signals. This study examined the extent to which exposure to the NMDA receptor antagonists ketamine and MK801, frequently used pharmacological models of schizophrenia, recreate deficits in electrophysiological markers of disturbed brain circuits that are thought to underlie the illness. Furthermore, this study characterizes the specificity of these differences across the frequency spectrum so as to help identify the nature of selective circuit abnormalities that mediate each oscillatory response as relevant to schizophrenia.
Mouse EEG was recorded during exposure to repeated auditory stimuli after injection of either vehicle or drug. The dose-response relationship for each electrophysiological measure was determined for ketamine and MK-801. Time-frequency analyses were performed to assess baseline, total, and evoked power and intertrial coherence (ITC) at low (5-10 Hz) and high (35-80 Hz)-frequencies.
High frequency evoked and total power was decreased by MK-801 and ketamine in a dose-dependent fashion. High frequency baseline power was increased by MK-801 and ketamine in a dose-dependent fashion. Similar to evoked power, high frequency inter-trial coherence was dose-dependently decreased by both drugs. Low frequency ITC was only decreased by ketamine.
Both ketamine and MK-801 cause alterations in high-frequency baseline (noise), total (signal), and evoked (signal) power resulting in a loss of high frequency SNR that is thought to primarily reflect local circuit activity. These changes indicate an inappropriate increase in baseline activity, which can also be interpreted as non-task related activity. Ketamine induced a loss of intertrial coherence at low frequencies, indicating a loss of consistency in low-frequency circuit mechanisms. As a proportion of baseline power, both drugs had a relative shift from low to high frequencies, reflecting a change in the balance of brain activity from coordination of global regions to a pattern of discoordinated, autonomous local activity. These changes are consistent with a pattern of fragmented regional brain activity seen in schizophrenia.
越来越多的证据表明,精神分裂症的功能缺陷可能是由于神经信号的信噪比(SNR)和一致性降低所致。本研究旨在探讨 NMDA 受体拮抗剂氯胺酮和 MK801 (常用于精神分裂症的药理学模型)在多大程度上再现了被认为是导致该疾病的大脑电路紊乱的电生理标记物的缺陷。此外,本研究还描述了这些差异在整个频谱上的特异性,以帮助确定介导每种振荡反应的特定电路异常的性质,这些反应与精神分裂症有关。
在注射载体或药物后,通过记录小鼠脑电图,在反复听觉刺激期间记录其脑电活动。确定氯胺酮和 MK-801 对每种电生理测量的剂量反应关系。进行时频分析,以评估低频(5-10 Hz)和高频(35-80 Hz)下的基线、总功率和诱发功率以及试验间相干性(ITC)。
MK-801 和氯胺酮以剂量依赖性方式降低高频诱发和总功率。MK-801 和氯胺酮以剂量依赖性方式增加高频基线功率。与诱发功率类似,高频 IT C 也被两种药物剂量依赖性地降低。低频 IT C 仅被氯胺酮降低。
氯胺酮和 MK-801 均导致高频基线(噪声)、总(信号)和诱发(信号)功率的改变,导致高频 SNR 的损失,这主要反映了局部回路活动。这些变化表明基线活动的不适当增加,也可以解释为与任务无关的活动。氯胺酮在低频时引起 IT C 的丧失,表明低频电路机制的一致性丧失。作为基线功率的一部分,两种药物都有从低频到高频的相对转移,反映了大脑活动的平衡从全局区域的协调到不协调、自主的局部活动模式的变化。这些变化与精神分裂症中观察到的区域性大脑活动碎片化模式一致。